System Transmission

Top Signal

100#1 JOB

Activity

2188Ripe

+959 today

System

Livenow

Terminal Asset View

stockNASDAQ

NVCR

$12.06+0.42%

NovoCure Ltd

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

31Neutral

Live Analysis Active

Company Mission

Gathering company mission...

NVC

Industry Context

This company operates in the medical technology sector, focusing on oncology treatments. It competes with traditional cancer therapies like chemotherapy and radiation, offering a non-invasive alternative. The industry is growing due to increasing cancer rates and demand for advanced care, but faces regulatory hurdles and high research costs.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

33Matrix

Market Momentum

45.9— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.3x— Normal Volume

Today's Change

0.42%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing NVCR across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 09:28 AM UTC

As-of As of 2026-03-16T09:13:25.767Z UTC (~15m delay).

Develops medical devices that use electric fields to treat cancer, generating revenue from sales and rentals to hospitals and patients.

Weekly chart shows range contraction, indicating a coiling pattern that often precedes breakouts near $15, suggesting potential momentum as volatility compresses.

Volume spiked 2x at $14, indicating institutional interest because large buyers may be accumulating shares ahead of earnings. Monitor if volume stays elevated above average.

Industry trend toward innovative cancer therapies is driving strength, with price holding above $13 support, signaling resilience in a competitive market.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...